
The Audacious Goals Initiative of the National Eye Institute is focused on developing noninvasive imaging advances to help patients with vision loss.

The Audacious Goals Initiative of the National Eye Institute is focused on developing noninvasive imaging advances to help patients with vision loss.

ASRS 2020 coverage: Intravitreal liposome-encapsulated bromfenac is under study as a treatment for refractory DME. Results of a pilot study were detailed at the virtual 2020 American Society of Retina Specialists (ASRS) annual meeting.

ASRS 2020 coverage: The Audacious Goals Initiative of the National Eye Institute is focused on developing noninvasive imaging advances to help patients with vision loss.




ICYMI: Dr. Clark breaks down the results of the PANORAMA Study

ICYMI: Dr. Singh shares the take-home message from his 2019 presentation

ICMYI: Dr. Wykoff discusses results from his ASRS presentation

Dr. Kaiser discusses how risuteganib fared in a phase II trial in patients with intermediate nonexudative AMD.

ICYMI: Dr. Blinder compares the efficiencies between two surgical cutters

Eyes with persistent subretinal fluid fared better with visual acuity than eyes that were dry, according to the HARBOR Trial

ICYMI: Abicipar Phase II MAPLE Trial supports improved safety for patients with nAMD following a Modified Manufacturing Process

This year’s ASRS PAT survey show subtle regional differences

The ASRS Global Trends Survey finds differences in some treatment preferences

ICYMI: ASRS-developed program aims to support physicians with confidential comparisons

Ever wondered what it's like to compete in a Shark Tank-like competition? Find out!

Optical coherence tomography angiography can detect microcirculatory disturbances during acute attacks.

Defining medicine and terms used can help move science forward

Researchers seeking fluid features, retinal integrity measures to test next step in image analysis and image interrogation in clinical trials.

David S. Boyer, MD, notes that the goal is to dry every patient out, with undertreatment the leading cause of a loss of visual acuity.

Researchers find that targeted subretinal delivery of stem cell derived RPE to geographic atrophy is feasible

Annual meeting schedule to include presentations, live surgery, awards

Beyond the sessions, this year’s conference offers multiple events for attendees.

Sunir J. Garg, MD, discusses hypersonic vitrector settings in surgery in the exhibition hall at ASRS 2018 in Vancouver.




